Curriculum vitae. Personal Details Prof. dr. Lonneke Veronique van de Poll-Franse

Transcription

1 CV Lonneke van de Poll-Franse, March2015- long -1 - Curriculum vitae Personal Details Name: Male/female: Date, place of birth: Nationality: Native country parents: Prof. dr. Lonneke Veronique van de Poll-Franse Female January 27, 1972 The Hague Dutch The Netherlands Masters University: Radboud University Nijmegen, The Netherlands. Date: September 1995 Main subject: Biomedical Health Sciences- Epidemiology Doctorate (PhD) University: VU University Amsterdam, The Netherlands Date: December 19, 2001 Supervisors: Prof. Jacques van Eijk, Prof. Rob Heine Title of thesis: Type 2 diabetes: Heterogeneity and clinical presentation Work Experience since graduating 2014-present Adjunct Professor University of Southern Denmark, Odense 2012-present Professor Cancer epidemiology and survivorship, Center of Research on Psychology in Somatic Diseases, Tilburg University & Comprehensive Cancer Centre the Netherlands Head Research Department at the Comprehensive Cancer Centre South/Eindhoven Cancer Registry Associate Professor, Center of Research on Psychology in Somatic Diseases, Tilburg University 2007 Research-fellow Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA Senior-researcher at the Comprehensive Cancer Centre South/Eindhoven Cancer Registry Researcher at the Comprehensive Cancer Centre South/Eindhoven Cancer Registry 2000 Research Fellow at Sticht Center on Aging, Wake Forest University, Winston- Salem, North Carolina, USA Research Fellow Department of Preventive Medicine, University of Tennessee, Memphis, TN, USA Ph.D. student, Faculty of Medicine, VU University, Amsterdam, The Netherlands. (International) Organisational and teaching activities 2014-present Chair EORTC-Quality of Life group Chair-elect of the EORTC-Quality of Life group 2013-present Member of Signalling Committee of the Dutch Cancer Society 2012-present Teacher/Coordinator of Introduction in Psychology and Health (2 nd year course Bachelor Students Psychology at Tilburg University) 2012-present Member of the Steering Committee of the international Diabetes and Cancer Research Consortium 2011-present Member of the Scientific Council for Socio-Oncological Research of the Dutch Cancer Society

2 CV Lonneke van de Poll-Franse, March2015- long present Teacher of Advanced Academic Skills (Master Medical Psychology at Tilburg University) Member of the editorial board of the European Journal of Cancer Member of the Executive Committee of the EORTC-Quality of Life group Chair of Committee Output of the Netherlands Cancer Registry: Coordinate usage of Netherlands Cancer Registry data for (inter)national or regional research activities Member of the Steering Committee of the Netherlands Cancer Registry: Lead and coordinate different committees of the Netherlands Cancer Registry Member of the Medical Ethics Committee of Maxima Medical Centre in Veldhoven: review of study proposals on methodological issues Teaching Evidence Based Medicine, Maxima Medical Centre Teaching at the University of Tilburg: Cancer Epidemiology Brief summary of research over the last years Trained as an epidemiologist, I have developed experience in the conduct, management and analyses of large population-based studies and trials. This has resulted in publications (189, see list of publications) that are generally well cited (>3500 citations, H-index=32). In the last years, my research has focused on cancer survivorship: the short- and long term physical and psychosocial consequences of cancer and its treatment. In 2009 I started the PROFILES (Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship) registry that combines population-based cancer registry data with patient reported outcomes ( PROFILES registry has collected PRO data from over cancer patients and survivors that I share with the academic community for free. As I obtained my PhD in diabetes research, I developed a special interest in the role of comorbidity in cancer survivorship and the mechanisms underlying the interaction between diseases, treatments and outcomes. More recently my research has shifted from doing mainly longitudinal observational studies to conducting intervention trials. I am currently the PI of two pragmatic cluster randomized trials and two individually randomized trials. All four trials investigate the hypothesized improvement of information provision, shared decision making, and survivorship care in patients with gynaecological cancer, prostate cancer or lymphoma. I am currently integrating my expertise in the field of cancer survivorship with the field of biological aging by collecting biomaterials from PROFILES participants. I want to understand why some cancer patients survive in relatively good health, while others develop numerous health problems after cancer and its treatment. International Collaborations Important international collaborations exist within: - The European Organisation of Research and treatment of Cancer (EORTC) QoL group has 140 active members (MDs, epidemiologists, psychologists, nurses) who meet twice per year. Since 2007 I participate in this group, in which we develop internationally validated QoL questionnaires and also conduct international field studies. I am the PI of two international EORTC module developments. I was member of the executive committee from 2009 to 2011, and now again since I became chair in September Diabetes and Cancer Study Group: This international consortium (MDs, epidemiologists, statisticians) includes 30 members and meets once a year to share research methodologies and collaborate in combined international studies and H2020 grant proposal. I am member of the steering committee of this group. One of my PhD students has worked in Canada with Jeff Johnson, University of Alberta, Edmonton studying diagnostic delay in diabetes and cancer patients. - European Cancer Pharmaco-epidemiology Researchers. This group MDs, epidemiologists, statisticians is collaborating in European Cancer Pharmaco-epidemiological analyses. There are only a few institutes in Europe that have access to pharmacy data linked to cancer registry data. Within this group we aim to optimize use of these linked databases by combining data and sharing new methodologies. One of my PhD students has worked in the group of Liam Murray from Queens University in Belfast, Northern Ireland to investigate the association of beta-blockers and breast cancer outcomes. - In 2007 I worked as a research-fellow at Jonsson Comprehensive Cancer Center, UCLA, in the group of Patti Ganz. In 2012, one of my PhD students also worked with Patti Ganz for 3 months on a project combining US and Dutch lymphoma survivorship data. - I work with epidemiologists from Cancer Registries of Belgium, Italy, France, Ireland, Germany and Australia on the start-up of international quality of life studies using the PROFILES infrastructure.

3 CV Lonneke van de Poll-Franse, March2015- long -3 - Relevant professional courses and training 2008 Clinimetrics, EMGO-Institute, Soesterberg 2004 Health Status Research, Erasmus MC, Rotterdam 2002 Advanced statistical courses on prediction of incidence and mortality and cancer survival analysis, Tampere Finland 2002 Cancer Epidemiology, Netherlands Cancer Institute, Amsterdam 2001 Basic course Oncology, Dutch Cancer Society 1999 Pharmaco epidemiology by M. Pahor, Department of Preventive Medicine, University of Tennessee, Memphis, TN, USA 1997 Writing English for Publication, Vrije Universiteit, Amsterdam 1997 Epidemiology Summer Course, New England Epidemiology Institute, Tufts University, Boston, MA,USA: Modern Epidemiology by K. Rothman; Regression analyses by S. Lemeshow 1996 Clinical Epidemiology by N. Weiss, Catholic University Nijmegen, Nijmegen 1996 Study design in epidemiologic research by O. Miettinen, EMGO-Institute, VU, Amsterdam Ph.D. Program, Department of Medical Psychology, Tilburg University, The Netherlands Completed PhD student trajectories under my supervision: Floortje Mols, MSc: Physical and psychological well-being among long-term cancer survivors. (Graduation: 2/3/2007) Cynthia Holterhues, MD: Burden of Melanoma (Graduation: 12/10/2011) Myrthe van Herk-Sukel, MSc: Medication use among women with breast cancer in the Netherlands (Graduation: 11/11/2011) Olga Husson, MSc: Information provision and patient reported outcomes in cancer survivors: with a special focus on thyroid cancer (Graduation: 1/3/2013) Corina van den Hurk, MSc: Effectiveness and safety of scalp Cooling in cancer patients undergoing cytotoxic treatment (Graduation: 19/09/2013) Simone Oerlemans, MSc: Late effects and long term health related quality of life in lymphoma patients (Graduation: 7/11/2014) Marjolein Zanders, MD: Diabetes and cancer - A dangerous liaison? The reciprocal impact of diabetes and cancer on outcomes with a special focus on drug effects (Graduation: 6/2/2015) Ongoing PhD student trajectories under my supervision: Kim Nicolaije, MSc: The impact of a cancer Survivorship Care Plan on patient reported outcomes and health care providers. A pragmatic cluster randomized controlled trial in endometrial cancer patients ( ) Pauline Vissers, MSc: Testing biologic interaction between diabetes and cancer on patient reported outcomes ( ) Rick Waalboer, MD: Symptoms and Quality of Life in skin cancer patients ( ) Maarten Cuypers, MSc: A randomized controlled trial investigating the impact of shared decision making in prostate cancer on patient reported outcomes ( ) Romy Lamers, MD: A randomized controlled trial investigating the impact of shared decision making in prostate cancer on treatment variation and health care use ( ) Tonneke Beijers, MD: The impact of chemotherapy on long-term peripheral neuropathy ( ) Mies van Eenbergen, MSc: The role of online cancer patient communities in well-being of cancer survivors ( ) Lindy Arts, MSc Lymphocare: A randomized controlled trial investigating the impact of an online intervention for lymphoma patients on self-management skills ( ) Jessy Joy van Kleef, MSc Stimulating evidence based information provision after oesophageal cancer diagnosis ( ) Vacant, to be hired: The long-term impact of a cancer Survivorship Care Plan on ovarian cancer patient reported outcomes. A pragmatic cluster randomized controlled trial ( )

4 CV Lonneke van de Poll-Franse, March2015- long -4 - Supervision of post-doctoral researchers that are currently working in my group: Melissa Thong; Nicole Ezendam; Olga Husson; Dounya Schoormans, Simone Oerlemans, Corina van den Hurk Awards, Grants and Scholarships 2009 Cancer Research Award- Dutch Cancer Society (see also Grants) 1998 Award from the American Society of Hypertension (ASH): ASH Recognition Award for Young Investigators-In-Training Award from Merck & Co.: Young Investigators Award Award from the Epidemiology section of the Catholic University Nijmegen: Best student epidemiology, Award from the faculty of Medicine of the Catholic University Nijmegen for scientific research done at the Netherlands Cancer Institute. Grants 2015 Stimulating evidence based, personalized and tailored information provision to improve decision making after oesophageal cancer diagnosis: SOurCE. Alpe d'huzes- Co-Investigator (PI van Laarhoven, AMC: ) 2015 ICT4CANCER: facilitating self-management and personalized access to supportive care in cancer survivors. Alpe d'huzes Co-Investigator (PI Verdonck-de Leeuw, VUMC : ) 2014 Validation of a neuropathy questionnaire for use in daily clinical practice. Janssen- Principal Investigator ( ) Development of an EORTC survivorship questionnaire. European Organisation for Research and Treatment of Cancer-Quality of Life Group)- Principal Investigator ( ) ENdometrial cancer SURvivors' follow-up care (ENSURE): Less is more? Randomized controlled trial to evaluate patient satisfaction and cost-effectiveness of a reduced follow-up schedule. Dutch Cancer Society (KWF Kankerbestrijding) Principal Investigator ( ) Lymphocare: A randomized controlled trial investigating the impact of an online intervention for lymphoma patients on self-management skills : Jonker-Driessen Stichting. Principal Investigator ( ) Development of a set of EORTC measures to assess QoL in lymphoproliferative disorders. European Organisation for Research and Treatment of Cancer-Quality of Life Group)- Principal Investigator ( ) Testing biologic interaction between diabetes and cancer on mortality and patient reported outcomes. (European Federation for the Study of Diabetes)- Principal Investigator ( ) The impact of a cancer Survivorship Care Plan on patient reported outcomes and health care providers. A pragmatic cluster randomized controlled trial. Dutch Cancer Society (KWF Kankerbestrijding) Principal Investigator ( ) Information disclosure and cancer survivorship care planning. Dutch Cancer Society (KWF Kankerbestrijding)- Cancer Research Award/ Personal Career Development. Principal Investigator ( ) Building an infrastructure for multidisciplinary and longitudinal data collection of the physical and psychosocial impact of cancer and its treatment: Patient Reported Outcomes Following Initial treatment and Long term Survivorship (PROFILES) : The Netherlands Organisation for Scientific Research (NWO-MaGW)- Medium Investment. Principal Investigator ( ) Quality of life and health care use among lymphoma survivors: a longitudinal population-based study in the Southeast Netherlands : Jonker-Driessen Stichting. Principal Investigator ( ) Impact of new systemic treatments of patients with hematological malignancies in the Netherlands: population-based cohort studies of process and outcome as a basis for assessments of costeffectiveness : Dure- en Weesgeneesmiddelen ZonMW. Co-investigator ( ) Fellowship Grant Dutch Cancer Society for a research-fellowship at Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA ( 6.000) Influence of scalp cooling on the incidence and prognosis of scalp skin metastasis in breast cancer : Doelmatigheidssubsidie ZonMW. Co-applicant ( ) Quality of life in lymphoma survivors : INTERZOL. Principal Investigator ( ) Quality of life in cancer survivors : Rotary Triborch, Tilburg. Principal Investigator ( ).

5 CV Lonneke van de Poll-Franse, March2015- long -5 - Invited lectures to international conferences/schools 1. Building international collaborations to improve cancer survivorship research and care. 7th Biennial Cancer Survivorship Research Conference. Atlanta, GA, USA, June Population-based quality of life research using the cancer registry. Quality of Life Assessment and Analysis in Oncology - Recent Methodological Developments. Institut régional du Cancer de Montpellier, France, April Assessment of quality of life and optimal methods for data collection. 1 st EORTC survivorship summit, Brussels, Belgium, January Pharmcaoepidemiological outcomes research in the Netherlands. International Cancer Pharmacoepidemiology Symposium. Dublin, Ireland, September Diabetes, Cancer and patient reported outcomes. 48 th Annual Meeting of the European Association for the Study of Diabetes. Berlin, Germany, October, Population-based quality of life research using the cancer registry. 34 th International Association of Cancer Registries (IACR) Conference. Cork, Ireland, September, Optimal cancer care on Aruba: The importance of Cancer Registry. Dr. E. Horacio E. Oduber Hospital Aruba. Aruba, July, Population-based quality of life research using the cancer registry. ESO-OECI International Symposium on Cancer Survivorship. Bari, Italy, April, Socio-economic implications of cancer survivorship. Association of European Cancer Leagues. Dublin, February, Quality of life research using the cancer registry. International EUROCOURSE Summit Meeting. Brussels, November, From Cancer Registry to Cancer Patient Registry: Quality of life research using the Cancer Registry. International EUROCOURSE Meeting work package 1 and work package 6. Amsterdam, April 12, 2011 and Amsterdam, September, Long-term impact of treatment for early stage endometrial cancer on quality of life: A populationbased study. International Gynecologic Cancer Society (IGCS) Prague. October, Development of a Melanoma Care Plan. Global Melanoma Task Force. Paris, April 16, Impact of pelvic lymphadenectomy on health related quality of life (HRQL) & psychometrics of the EORTC-EN34. EORTC (European Organisation for Research and Treatment of Cancer) Gynae-QoL group. Brussels, March, Quality of life among melanoma survivors & survivorship care plan. Global Melanoma Task Force. The Hague; October 'Cancer survivorship research in the Netherlands'. Jonsson Comprehensive Cancer Centre. University of California, Los Angeles; June, Increasing prevalence of cancer patients with diabetes - implications for clinical care. Annual Research Meeting UK and Dutch Cancer Registries. London; October, 'Cancer in the Netherlands: Trends, predictions and implications for health care'. University of Antwerp. Antwerp; June, Association of fasting plasma insulin with markers of fibrinolysis and inflammation in persons with hypertension and type 2 diabetes. Sticht Center on Aging, Wake Forest University, Winston-Salem NC, USA, March, Serum uric acid, hypokalemia, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). Epidemiology, Demography and Biometry program, National Institute on Aging, Bethesda MD, USA; May Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) American Society of Hypertension Annual Meeting, New York, USA; May INVITED LECTURES TO NATIONAL MEETINGS/SCHOOLS In addition to invited lectures to international meetings, regular acceptance of abstracts for oral presentations on international meetings, I present on average 4 to 8 times per year my research at clinical, epidemiological or psycho-oncology meetings or university departments in the Netherlands.

6 CV Lonneke van de Poll-Franse, March2015- long -6 - Publications, June 2015 H-Index: 32 (source: Web of Science) In bold publications in journals with IF>5 1. Nicolaije KAH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Boss EA, Hermans RHM, Engelhart KCM, Haartsen JE, Pijlman BM, van Loon-Baelemans IEAM, Mertens HJMM, Nolting, WJ, van Beek JJ, Roukema JA, Zijlstra WP, Kruitwagen RFPM, van de Poll-Franse LV. The Impact of an Automatically Generated Cancer Survivorship Care Plan on Patient Reported Outcomes in Routine Clinical Practice: Longitudinal Outcomes of the Pragmatic Cluster Randomized ROGY Care Trial. J Clin Oncol. 2015, in press. 2. Bours MJ, Beijer S, Winkels RM, van Duijnhoven FJ, Mols F, Breedveld-Peters JJ, Kampman E, Weijenberg MP, van de Poll-Franse LV. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry. Br J Nutr Jun 16: Dirven L, van de Poll-Franse LV, Aaronson NK, Reijneveld JC. Controversies in defining cancer survivorship. Lancet Oncol Jun;16(6): Cuypers M, Lamers RE, Kil PJ, van de Poll-Franse LV, de Vries M. Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial. Trials May 27;16(1): Verhaar S, Vissers PA, Maas H, van de Poll-Franse LV, van Erning FN, Mols F. Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: Results from the population-based PROFILES registry. Eur J Cancer Jul;51(10): Horevoorts NJ, Vissers PA, Mols F, Thong MS, van de Poll-Franse LV. Response rates for patientreported outcomes using web-based versus paper questionnaires: comparison of two invitational methods in older colorectal cancer patients. J Med Internet Res May 7;17(5) 7. Oerlemans S, Nijziel MR, van de Poll-Franse LV. Age-related differences in quality of life among patients with diffuse large B-cell lymphoma. Cancer Apr Zanders MM, Haak HR, van Herk-Sukel MP, van de Poll-Franse LV, Johnson JA. Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F [letter]. Diabetologia Jun;58(6): Vissers PA, Cardwell CR, van de Poll-Franse LV, Young IS, Pouwer F, Murray LJ. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes. Breast Cancer Res Treat Mar Vissers PA, Mols F, Thong MS, Pouwer F, Vreugdenhil G, van de Poll-Franse LV. The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry. J Cancer Surviv Feb Zanders MM, Haak HR, van Herk-Sukel MP, van de Poll-Franse LV, Johnson JA. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes. Diabetologia Feb Husson O, Mols F, Ezendam NP, Schep G, van de Poll-Franse LV. Health-related quality of life is associated with physical activity levels among colorectal cancer survivors: a longitudinal, 3-year study of the PROFILES registry. J Cancer Surviv Jan Husson O, Mols F, van de Poll-Franse LV, de Vries J, Schep G, Thong MS. Variation in fatigue among 6011 (long-term) cancer survivors and a normative population: a study from the population-based PROFILES registry. Support Care Cancer Jan van der Poel MW, Oerlemans S, Schouten HC, van de Poll-Franse LV. Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol Apr;94(4): Beijers AJ, Mols F, Tjan-Heijnen VC, Faber CG, van de Poll-Franse LV, Vreugdenhil G. Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry. Acta Oncol Nov 24:1-7.

7 CV Lonneke van de Poll-Franse, March2015- long van der Putten LJ, Geels YP, Ezendam NP, van der Putten HW, Snijders MP, van de Poll-Franse LV, Pijnenborg JM. Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer. Int J Gynecol Cancer Jan;25(1): Winstanley JB, Young TE, Boyle FM, Bergenmar M, Bottomley A, Burmeister B, Campana LG, Garioch JJ, King M, Nikolic DV, van de Poll-Franse LV, Saw R, Thompson JF, White EG; European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Res Feb;25(1): Zanders MM, Renehan AG, Bowker SL, Carstensen B, van de Poll-Franse LV, Johnson JA. Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37: Diabetes Care Oct;37(10):e Ezendam NP, Pijlman B, Bhugwandass C, Pruijt JF, Mols F, Vos MC, Pijnenborg JM, van de Poll-Franse LV. Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry. Gynecol Oncol Dec;135(3): Husson O, Mols F, Fransen MP, van de Poll-Franse LV, Ezendam NP. Low subjective health literacy is associated with adverse health behaviors and worse health-related quality of life among colorectal cancer survivors: results from the profiles registry. Psychooncology Sep Beekers N, Husson O, Mols F, van Eenbergen M, van de Poll-Franse LV. Symptoms of Anxiety and Depression Are Associated With Satisfaction With Information Provision and Internet Use Among 3080 Cancer Survivors: Results of the PROFILES Registry. Cancer Nurs Sep Daniëls LA, Krol SD, de Graaf MA, Scholte AJ, van 't Veer MB, Putter H, de Roos A, Schalij MJ, van de Poll-Franse LV, Creutzberg CL. Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys Sep 1;90(1): van den Broek EC, Oerlemans S, Nijziel MR, Posthuma EF, Coebergh JW, van de Poll-Franse LV. Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands. Ann Hematol Jan;94(1): Vissers PA, Thong MS, Pouwer F, den Oudsten BL, Nieuwenhuijzen GA, van de Poll-Franse LV. The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry. Support Care Cancer Nov;22(11): Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse LV, Joosse A, Schilling B, Nijsten T, Schadendorf D, de Vries E. Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study. Cancer Med Oct;3(5): Ezendam NP, Nicolaije KA, Kruitwagen RF, Pijnenborg JM, Vos MC, Boll D, van Bommel M, van de Poll- Franse LV. Survivorship Care Plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial. J Cancer Surviv Dec;8(4): van Leeuwen M, Efficace F, Fosså SD, Bolla M, De Giorgi U, de Wit R, Holzner B, van de Poll-Franse LV, van Poppel H, White J, Collette L, Osanto S, Aaronson NK; European Organisation for Research and Treatment of Cancer Quality of Life Group; Genito-Urinary Cancers Group; Radiation Oncology Group. Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. Eur J Cancer Jul;50(11): Oerlemans S, Mols F, Nijziel MR, Zijlstra WP, Coebergh JW, van de Poll-Franse LV. The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry. J Cancer Surviv Dec;8(4): Husson O, Mols F, Oranje WA, Haak HR, Nieuwlaat WA, Netea-Maier RT, Smit JW, van de Poll-Franse LV. Unmet information needs and impact of cancer in (long-term) thyroid cancer survivors: results of the PROFILES registry. Psychooncology Mar Zanders MM, Vissers PA, Haak HR, van de Poll-Franse LV. Colorectal cancer,diabetes and survival: Epidemiological insights. Diabetes Metab Feb 4. Review. 31. Husson O, Oerlemans S, Mols F, Smeets RE, Poortmans PM, van de Poll-Franse LV. Satisfaction with information provision is associated with baseline but not with follow-up quality of life among lymphoma patients: Results from the PROFILES registry. Acta Oncol Jan Daniëls LA, Oerlemans S, Krol AD, Creutzberg CL, van de Poll-Franse LV. Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer Feb 18;110(4):

8 CV Lonneke van de Poll-Franse, March2015- long Zanders MM, Vissers PA, van de Poll-Franse LV. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication? J Clin Oncol Mar 1;32(7): Nicolaije KA, Ezendam NP, Vos MC, Pijnenborg JM, van de Poll-Franse LV,Kruitwagen RF. Oncology providers' evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY Care trial. J Cancer Surviv Dec van der Poel MW, Oerlemans S, Schouten HC, Mols F, Pruijt JF, Maas H, van de Poll-Franse LV. Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry. Ann Hematol Dec van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. Breast Feb;23(1): van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW. Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia. Acta Oncol Jan;53(1): van den Hurk CJ, van de Poll-Franse LV, Breed WP, Coebergh JW, Nortier JW. Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. Breast Oct;22(5): Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Nijsten T, Schadendorf D, de Vries E. β-blocker use and all-cause mortality of melanoma patients: results from a populationbased Dutch cohort study. Eur J Cancer Dec;49(18): Vissers PA, Thong MS, Pouwer F, Zanders MM, Coebergh JW, van de Poll-Franse LV. The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv Ezendam NP, Nicolaije KA, Boll D, Lybeert ML, Mols F, Pijnenborg JM, van de Poll-Franse LV. Health care use among endometrial cancer survivors: a study from PROFILES, a population-based survivorship registry. Int J Gynecol Cancer Sep;23(7): Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol Jul 20;31(21): Zanders MM, van Steenbergen LN, Haak HR, Rutten HJ, Pruijt JF, Poortmans PM, Lemmens VE, van de Poll-Franse LV. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study. Diabet Med Oct;30(10): Daniëls LA, Oerlemans S, Krol AD, van de Poll-Franse LV, Creutzberg CL. Persisting fatigue in Hodgkin lymphoma survivors: a systematic review. Ann Hematol Aug;92(8): Andrykowski MA, Aarts MJ, van de Poll-Franse LV, Mols F, Slooter GD, Thong MS. Low socioeconomic status and mental health outcomes in colorectal cancer survivors: disadvantage? advantage?... or both? Psychooncology Nov;22(11): Thong MS, Mols F, Stein KD, Smith T, Coebergh JW, van de Poll-Franse LV. Population-based cancer registries for quality-of-life research: a work-in-progress resource for survivorship studies? Cancer Jun 1;119 Suppl 11: Review. 47. Mols F, Husson O, Roukema JA, van de Poll-Franse LV. Depressive symptoms are a risk factor for allcause mortality: results from a prospective population-based study among 3,080 cancer survivors from the PROFILES registry. J Cancer Surviv Sep;7(3): van Herk-Sukel MP, van de Poll-Franse LV, Creemers GJ, Lemmens VE, van der Linden PD, Herings RM, Coebergh JW, Voogd AC. Major changes in chemotherapy regimens administered to breast cancer patients during in the Netherlands. Breast J Jul-Aug;19(4): Kerkhofs TM, Verhoeven RH, Bonjer HJ, van Dijkum EJ, Vriens MR, De Vries J, Van Eijck CH, Bonsing BA, Van de Poll-Franse LV, Haak HR; Dutch Adrenal Network. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. Eur J Endocrinol Jun 7;169(1): Husson O, Nieuwlaat WA, Oranje WA, Haak HR, van de Poll-Franse LV, Mols F. Fatigue among shortand long-term thyroid cancer survivors: results from the population-based PROFILES registry. Thyroid Oct;23(10):

9 CV Lonneke van de Poll-Franse, March2015- long van den Hurk CJ, van den Akker-van Marle ME, Breed WP, van de Poll-Franse LV, Nortier JW, Coebergh JW. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. Eur J Oncol Nurs Oct;17(5): Kerkhofs TM, Verhoeven RH, Van der Zwan JM, Dieleman J, Kerstens MN, Links TP, Van de Poll- Franse LV, Haak HR. Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since Eur J Cancer Jul;49(11): Thong MS, Mols F, Wang XS, Lemmens VE, Smilde TJ, van de Poll-Franse LV. Quantifying fatigue in (long-term) colorectal cancer survivors: a study from the population-based patient reported outcomes following initial treatment and long term evaluation of survivorship registry. Eur J Cancer May;49(8): Husson O, Haak HR, van Steenbergen LN, Nieuwlaat WA, van Dijk BA, Nieuwenhuijzen GA, Karim-Kos H, Kuijpens JL, van de Poll-Franse LV, Coebergh JW. Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since Endocr Relat Cancer Mar 26;20(2): Husson O, Thong MS, Mols F, Smilde TJ, Creemers GJ, van de Poll-Franse LV. Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registry. J Palliat Med Mar;16(3): Nicolaije KA, Ezendam NP, Vos MC, Boll D, Pijnenborg JM, Kruitwagen RF, Lybeert ML, van de Poll- Franse LV. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry. Gynecol Oncol May;129(2): Oldenburg CS, Boll D, Nicolaije KA, Vos MC, Pijnenborg JM, Coebergh JW, Beijer S, van de Poll-Franse LV, Ezendam NP. The relationship of body mass index with quality of life among endometrial cancer survivors: a study from the population-based PROFILES registry. Gynecol Oncol Apr;129(1): Thong MS, Mols F, Verhoeven RH, Liu L, Andrykowski MA, Roukema JA, van de Poll-Franse LV. Multiple primary cancer survivors have poorer health status and well-being than single primary cancer survivors: a study from the population-based PROFILES registry. Psychooncology Aug;22(8): Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F, Kuijpens JL, Coebergh JW, van de Poll-Franse LV. Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol Feb;52(2): Orsini RG, Thong MS, van de Poll-Franse LV, Slooter GD, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH. Quality of life of older rectal cancer patients is not impaired by a permanent stoma. Eur J Surg Oncol Feb;39(2): Boll D, Karim-Kos HE, Verhoeven RH, Burger CW, Coebergh JW, van de Poll-Franse LV, van Doorn HC. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study. Eur J Obstet Gynecol Reprod Biol Feb;166(2): Zanders MM, Boll D, van Steenbergen LN, van de Poll-Franse LV, Haak HR. Effect of diabetes on endometrial cancer recurrence and survival. Maturitas Jan;74(1): Husson O, Haak HR, Mols F, Nieuwenhuijzen GA, Nieuwlaat WA, Reemst PH, Huysmans DA, Toorians AW, van de Poll-Franse LV. Development of a disease-specific health-related quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors. Acta Oncol Sep Oerlemans S, Mols F, Issa DE, Pruijt JF, Peters WG, Lybeert M, Zijlstra W, Coebergh JW, van de Poll- Franse LV. A high level of fatigue among (long-term) non-hodgkin lymphoma survivors: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica Aug Oerlemans S, Smith SK, Crespi CM, Zimmerman S, van de Poll-Franse LV, Ganz PA. Assessing the impact of cancer among Dutch non-hodgkin lymphoma survivors compared with their American counterparts: a cross-national study. Psychooncology Jul Mols F, Oerlemans S, Vos AH, Koster A, Verelst S, Sonneveld P, van de Poll-Franse LV. Health-related quality of life and disease-specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population-based study using the PROFILES registry. Eur J Haematol Oct;89(4):311-9.

10 CV Lonneke van de Poll-Franse, March2015- long Soerjomataram I, Thong MS, Ezzati M, Lamont EB, Nusselder WJ, van de Poll-Franse LV. Most olorectal cancer survivors live a large proportion of their remaining life in good health. Cancer Causes Control Sep;23(9): van de Poll-Franse LV, Pijnenborg JM, Boll D, Vos MC, van den Berg H, Lybeert ML, de Winter K, Kruitwagen RF. Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: A large population-based study. Gynecol Oncol Oct;127(1): Nicolaije KA, Husson O, Ezendam NP, Vos MC, Kruitwagen RF, Lybeert ML, van de Poll-Franse LV. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: A study from the population-based PROFILES registry. Patient Educ Couns Sep;88(3): Oerlemans S, Husson O, Mols F, Poortmans P, Roerdink H, Daniels LA, Creutzberg CL, van de Poll- Franse LV. Perceived information provision and satisfaction among lymphoma and multiple myeloma survivors-results from a Dutch population-based study. Ann Hematol Oct;91(10): Den Oudsten BL, Traa MJ, Thong MS, Martijn H, De Hingh IH, Bosscha K, van de Poll-Franse LV. Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: A population-based study. Eur J Cancer May Buffart LM, Thong MS, Schep G, Chinapaw MJ, Brug J, van de Poll-Franse LV. Self-reported physical activity: its correlates and relationship with health-related quality of life in a large cohort of colorectal cancer survivors. PLoS One. 2012;7(5):e van de Poll-Franse LV, Haak HR, Coebergh JW, Janssen-Heijnen ML, Lemmens VE. Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia Aug;55(8): Maaskant-Braat AJ, Voogd AC, van de Poll-Franse LV, Coebergh JW, Nieuwenhuijzen GA. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node. Breast Aug;21(4): Mols F, Oerlemans S, Denollet J, Roukema JA, van de Poll-Franse LV. Type D personality is associated with increased comorbidity burden and health care utilization among 3080 cancer survivors. Gen Hosp Psychiatry Jul-Aug;34(4): Soerjomataram I, Thong MS, Korfage IJ, Polinder S, van der Heide A, de Vries E, Rietjens JA, Otto SJ, van de Poll-Franse LV. Excess weight among colorectal cancer survivors: target for intervention. J Gastroenterol Sep;47(9): Husson O, Thong MS, Mols F, Oerlemans S, Kaptein AA, van de Poll-Franse LV. Illness perceptions in cancer survivors: what is the role of information provision? Psychooncology Feb van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry. Acta Oncol Feb Mols F, Thong MS, Vissers P, Nijsten T, van de Poll-Franse LV. Socio-economic implications of cancer survivorship: Results from the PROFILES registry. Eur J Cancer Dec Nout RA, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, Nijman HW, van de Poll-Franse LV, Creutzberg CL. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer Holterhues C, van de Poll-Franse LV, de Vries E, Neumann HA, Nijsten TE. Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population. J Eur Acad Dermatol Venereol Oct van de Poll-Franse LV, Nicolaije KAH, Vos MC, Pijnenborg JMA, Boll D, Ezendam NPM, Boss EA, Hermans RHM, Engelhart KCM, Haartsen JE, Pijlman BM, Feijen HWH, Mertens HJJM, Nolting EWE, van Beek JJ, Roukema JA, Kruitwagen RFPM. Rationale and Design of ROGY Care: A pragmatic cluster randomized controlled trial in gynecological cancer patients to assess the impact of a cancer Survivorship Care Plan on patient and health care provider reported outcomes. Trials Mols F, Thong MSY, van de Poll-Franse LV, Roukema JA, Denollet J. Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. J Affect Disord Van Herk-Sukel MP, Lemmens VE, van de Poll-Franse LV, Herings RM, Coebergh JWW. Record linkage for pharmacoepidemiological studies in cancer patients. Pharmacoepidemiol. Drug Saf. 2011, Aug 2.

11 CV Lonneke van de Poll-Franse, March2015- long Oerlemans S, Mols F, Nijziel MR, Lybeert M, van de Poll-Franse LV. The impact of treatment, sociodemographic and clinical characteristics on health-related quality of life among Hodgkin's and non- Hodgkin's lymphoma survivors: a systematic review. Ann Hematol Jun Creutzberg CL, Nout RA, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras E, van de Poll-Franse LV, van Putten WL; PORTEC study group. Fifteen-Year Radiotherapy Outcomes of the Randomized PORTEC-1 Trial for Endometrial Carcinoma. Int J Radiat Oncol Biol Phys Jun van de Poll-Franse LV, Horevoorts N, Eenbergen MV, Denollet J, Roukema JA, Aaronson NK, Vingerhoets A, Coebergh JW, de Vries J, Essink-Bot ML, Mols F; The Profiles Registry Group. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer May Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV. Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol (Oxf) May van de Poll-Franse LV, Lemmens VE, Roukema JA, Coebergh JW, Nieuwenhuijzen GA. Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival. Br J Surg Jul;98(7): Lehmann V, Oerlemans S, van de Poll-Franse LV, Vingerhoets AJ, Mols F. Suffering in long-term cancer survivors: An evaluation of the PRISM-R2 in a population-based cohort. Qual Life Res Apr Thong MS, Mols F, Lemmens VE, Creemers GJ, Slooter GD, van de Poll-Franse LV. Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based study. Eur J Cancer Mar Thong MS, Mols F, Lemmens VE, Rutten HJ, Roukema JA, Martijn H, van de Poll-Franse LV. Impact of Preoperative Radiotherapy on General and Disease-Specific Health Status of Rectal Cancer Survivors: A Population-Based Study. Int J Radiat Oncol Biol Phys Feb Nout RA, van de Poll-Franse LV, Lybeert ML, Wárlám-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras B, van Putten WL, Creutzberg CL. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol May 1;29(13): Holterhues C, Cornish D, van de Poll-Franse LV, Krekels G, Koedijk F, Kuijpers D, Coebergh JW, Nijsten T. Impact of melanoma on patients' lives among 562 survivors: a Dutch population-based study. Arch Dermatol. 2011Feb;147(2): van den Hurk CJ, Eckel R, van de Poll-Franse LV, Coebergh JW, Nortier JW, Hölzel D, Breed WP, Engel J. Unfavourable pattern of metastases in M0 breast cancer patients during : a populationbased analysis of the Munich Cancer Registry. Breast Cancer Res Treat Aug;128(3): Ruiterkamp J, Ernst MF, de Munck L, van der Heiden-van der Loo M, Bastiaannet E, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Improved survival of patients with primary distant metastatic breast cancer in the period of A nationwide population-based study in the Netherlands. Breast Cancer Res Treat Jul;128(2): Epub 2011 Jan van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, Verdonck-de Leeuw IM, Taphoorn MJ, Aaronson NK. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer Mar;47(5): Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and healthrelated quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol Apr;22(4): Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV. Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol Oct;163(4): Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, Waldenström AC, Bergmark K, Chie WC, Kuljanic K, Costantini A, Singer S, Koensgen D, Menon U, Daghofer F; EORTC Quality of Life Group. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire- Endometrial Cancer Module (EORTC QLQ-EN24). Eur J Cancer Jan;47(2): Daskivich TJ, van de Poll-Franse LV, Kwan L, Sadetsky N, Stein DM, Litwin MS. From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer. Prostate Cancer Prostatic Dis Dec;13(4):320-7.

12 CV Lonneke van de Poll-Franse, March2015- long Aarts MJ, Mols F, Thong MS, Louwman MW, Coebergh JW, van de Poll-Franse LV. Long-term prostate cancer survivors with low socioeconomic status reported worse mental health-related quality of life in a population-based study. Urology Nov;76(5): Maaskant-Braat AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Roumen RM, Nolthenius-Puylaert MC, Nieuwenhuijzen GA. Sentinel node micrometastases in breast cancer do not affect prognosis: a population-based study. Breast Cancer Res Treat May;127(1): Epub 2010 Aug van Steenbergen LN, van de Poll-Franse LV, Wouters MW, Jansen-Landheer ML, Coebergh JW, Struikmans H, Tjan-Heijnen VC, van de Velde CJ. Variation in management of early breast cancer in the Netherlands, Eur J Surg Oncol Sep;36 Suppl 1:S Derkx F, Maaskant-Braat AJ, van der Sangen MJ, Nieuwenhuijzen GA, van de Poll-Franse LV, Roumen RM, Voogd AC. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure. Eur J Surg Oncol Jul;36(7): Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, Vd Wurff AA, Bosscha K, Coebergh JW. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer Apr;46(6): Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Well-being, posttraumatic growth and benefit finding in long-term breast cancer survivors. Psychol Health Jun;24(5): Lammers EJ, Huibers P, van der Sangen MJ, van de Poll-Franse LV, Poortmans PM, Ernst MF, Lemaire BM, Meijs CM, Nuytinck HK, Voogd AC. Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or younger. Breast Feb;19(1): Mols F, Holterhues C, Nijsten T, van de Poll-Franse LV. Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer Feb;46(3): Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, Vreugdenhil G, Pruijt JF, Coebergh JW, Herings RM. New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer van Herk-Sukel MP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Coebergh JW, Herings RM. Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis. Breast Cancer Res Treat van der Aa MA, Siesling S, vd Poll-Franse LV, Schutter EM, Lybeert ML, Coebergh JW. Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands Eur J Obstet Gynecol Reprod Biol 2009; 147(1): Sanli I, Lemaire BM, Muller AJ, van Kleffens HJ, Van Poll-Franse LV, van Dijk M. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term. Breast J 2009; 15(3): Thong MS, Mols F, Coebergh JW, Roukema JA, van de Poll-Franse LV. The impact of disease progression on perceived health status and quality of life of long-term cancer survivors. J Cancer Surviv 2009; 3(3): Thong MS, Mols F, Kil PJ, Korfage IJ, van de Poll-Franse LV. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int Ruiterkamp J, Ernst MF, van de Poll-Franse LV, Bosscha K, Tjan-Heijnen VC, Voogd AC. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol 2009; 35(11): Mols F, van de Poll-Franse LV. Employment status among cancer survivors. JAMA 2009; 302(1):32-33; author reply Mols F, Holterhues C, Nijsten T, van de Poll-Franse LV. Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer van de Poll-Franse L, Coebergh JW. Long-term mortality in cancer patients with preexisting diabetes. JAMA 2009; 301(15):1541; author reply Wildiers H, Van Calster B, van de Poll-Franse LV, Hendrickx W, Roislien J, Smeets A, Paridaens R, Deraedt K, Leunen K, Weltens C, Van Huffel S, Christiaens MR, Neven P. Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol 2009; 27(18):

13 CV Lonneke van de Poll-Franse, March2015- long Mols F, Thong MS, Vreugdenhil G, van de Poll-Franse LV. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology Mols F, Korfage IJ, Vingerhoets AJ, Kil PJ, Coebergh JW, Essink-Bot ML, van de Poll-Franse LV. Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys 2009; 73(1): Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, Nieuwenhuijzen GA. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 2009; 113(1): Duijm LE, Louwman MW, Groenewoud JH, van de Poll-Franse LV, Fracheboud J, Coebergh JW. Interobserver variability in mammography screening and effect of type and number of readers on screening outcome. Br J Cancer 2009; 100(6): Cornish D, Holterhues C, van de Poll-Franse LV, Coebergh JW, Nijsten T. A systematic review of health-related quality of life in cutaneous melanoma. Ann Oncol 2009; 20 Suppl 6:vi van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, van de Poll-Franse LV. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2009; 115(1): van de Poll-Franse LV, van Eenbergen MC. Internet use by cancer survivors: current use and future wishes. Support Care Cancer 2008; 16(10): van de Poll-Franse LV, Sadetsky N, Kwan L, Litwin MS. Severity of cardiovascular disease and healthrelated quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE. Qual Life Res 2008; 17(6): van de Poll-Franse LV, Kwan L, Reiter RE, Lee SP, Litwin MS. The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study. J Urol 2008; 179(4): ; discussion Sukel MP, van de Poll-Franse LV, Nieuwenhuijzen GA, Vreugdenhil G, Herings RM, Coebergh JW, Voogd AC. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period in the southeastern Netherlands. Eur J Cancer 2008; 44(13): Mols F, Korfage IJ, Vingerhoets AJ, Kil PJ, Coebergh JW, Essink-Bot ML, van de Poll-Franse LV. Bowel, Urinary, and Sexual Problems Among Long-Term Prostate Cancer Survivors: A Population-Based Study. Int J Radiat Oncol Biol Phys Mols F, Aquarius AE, Essink-Bot ML, Aaronson NK, Kil PJ, van de Poll-Franse LV. Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study. BJU Int Maaskant AJ, van de Poll-Franse LV, Voogd AC, Coebergh JW, Tutein Nolthenius-Puylaert MC, Nieuwenhuijzen GA. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 2009; 113(1): Korfage IJ, Essink-Bot ML, Mols F, van de Poll-Franse L, Kruitwagen R, van Ballegooijen M. Healthrelated quality of life in cervical cancer survivors: a population-based survey. Int J Radiat Oncol Biol Phys 2009; 73(5): Ho VK, van der Heiden-van der Loo M, Rutgers EJ, van Diest PJ, Hobbelink MG, Tjan-Heijnen VC, Dirx MJ, Reedijk AM, van Dijck JA, van de Poll-Franse LV, Schaapveld M, Peeters PH. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands. Eur J Cancer 2008; 44(5): Duijm LE, Groenewoud JH, de Koning HJ, Coebergh JW, van Beek M, Hooijen MJ, van de Poll-Franse LV. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography. Eur J Cancer 2009; 45(5): Diepenmaat LA, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, van Berlo CL, Luiten EJ, Nieuwenhuijzen GA, Voogd AC. The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer. Radiother Oncol 2009; 91(1): den Dulk M, Krijnen P, Marijnen CA, Rutten HJ, van de Poll-Franse LV, Putter H, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, Coebergh JW, van de Velde CJ. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer 2008; 44(12): van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, van Berlo CL, van de Poll-Franse LV. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 2007; 43(3):

14 CV Lonneke van de Poll-Franse, March2015- long van der Schaft DW, Pauwels P, Hulsmans S, Zimmermann M, van de Poll-Franse LV, Griffioen AW. Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site. Cancer Lett 2007; 254(1): van der Leest M, Evers L, van der Sangen MJ, Poortmans PM, van de Poll-Franse LV, Vulto AJ, Nieuwenhuijzen GA, Brenninkmeijer SJ, Creemers GJ, Voogd AC. The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years. Cancer 2007; 109(10): van den Broek N, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, Nieuwenhuijzen GA, Voogd AC. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 2007; 105(1): van de Schans SA, Janssen-Heijnen ML, Biesma B, Smeenk FW, van de Poll-Franse LV, Seynaeve C, Coebergh JW. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer 2007; 43(15): van de Poll-Franse LV, Mols F, Essink-Bot ML, Haartsen JE, Vingerhoets AJ, Lybeert ML, van den Berg HA, Coebergh JW. Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. Int J Radiat Oncol Biol Phys 2007; 69(1): van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007; 120(9): Siesling S, van de Poll-Franse LV, Jobsen JJ, Repelaer van Driel OJ, Voogd AC. Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, Breast 2007; 16(6): Rutten H, den Dulk M, Lemmens V, Nieuwenhuijzen G, Krijnen P, Jansen-Landheer M, van de Poll Franse L, Coebergh JW, Martijn H, Marijnen C, van de Velde C. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer 2007; 43(15): Mols F, Helfenrath KA, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Increased health care utilization among long-term cancer survivors compared to the average Dutch population: a population-based study. Int J Cancer 2007; 121(4): Mols F, Coebergh JW, van de Poll-Franse LV. Health-related quality of life and health care utilisation among older long-term cancer survivors: a population-based study. Eur J Cancer 2007; 43(15): Mols F, Aaronson NK, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Lybeert ML, van de Poll-Franse LV. Quality of life among long-term non-hodgkin lymphoma survivors: a population-based study. Cancer 2007; 109(8): Louwman WJ, van de Poll-Franse LV, Fracheboud J, Roukema JA, Coebergh JW. Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study. Breast Cancer Res Treat 2007; 105(3): Lemmens VE, Janssen-Heijnen ML, Houterman S, Verheij KD, Martijn H, van de Poll-Franse L, Coebergh JW. Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg 2007; 31(1): Kuijt GP, van de Poll-Franse LV, Voogd AC, Nieuwenhuijzen GA, Roumen RM. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 2007; 33(7): Ernst MF, van de Poll-Franse LV, Roukema JA, Coebergh JW, van Gestel CM, Vreugdenhil G, Louwman MJ, Voogd AC. Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and Breast 2007; 16(4): Bielska-Lasota M, Inghelmann R, van de Poll-Franse L, Capocaccia R. Trends in cervical cancer survival in Europe, : a population-based study. Gynecol Oncol 2007; 105(3): van Oost FJ, Luiten EJ, van de Poll-Franse LV, Coebergh JW, van den Eijnden-van Raaij AJ. Outcome of surgical treatment of pancreatic, peri-ampullary and ampullary cancer diagnosed in the south of The Netherlands: a cancer registry based study. Eur J Surg Oncol 2006; 32(5): van Dis FW, Mols F, Vingerhoets AJ, Ferrell B, van de Poll-Franse LV. A validation study of the Dutch version of the Quality of Life-Cancer Survivor (QOL-CS) questionnaire in a group of prostate cancer survivors. Qual Life Res 2006; 15(10):

15 CV Lonneke van de Poll-Franse, March2015- long van der Sangen MJ, van de Poll-Franse LV, Roumen RM, Rutten HJ, Coebergh JW, Vreugdenhil G, Voogd AC. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol 2006; 32(1): van de Poll-Franse LV, Mols F, Vingerhoets AJ, Voogd AC, Roumen RM, Coebergh JW. Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer 2006; 14(5): Shahir MA, Lemmens VE, van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 2006; 42(17): Mols F, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Aaronson NK, Lybeert ML, van de Poll-Franse LV. Better quality of life among year survivors of Hodgkin's lymphoma compared to 5-9 year survivors: a population-based study. Eur J Cancer 2006; 42(16): Mols F, van de Poll-Franse LV, Vingerhoets AJ, Hendrikx A, Aaronson NK, Houterman S, Coebergh JW, Essink-Bot ML. Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 2006; 107(9): Manders K, van de Poll-Franse LV, Creemers GJ, Vreugdenhil G, van der Sangen MJ, Nieuwenhuijzen GA, Roumen RM, Voogd AC. Clinical management of women with metastatic breast cancer: a descriptive study according to age group. BMC Cancer 2006; 6: Kuijt GP, van de Poll-Franse LV, Roumen RM, van Beek MW, Voogd AC. The significance of one positive axillary node. Eur J Surg Oncol 2006; 32(2): Houterman S, Janssen-Heijnen ML, van de Poll-Franse LV, Brenner H, Coebergh JW. Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. Ann Oncol 2006; 17(4): Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 2005; 41(17): Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheijmans LJ, van Beek MW, Roumen RM. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol 2005; 31(5): de Vries E, van de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JW. Predictions of skin cancer incidence in the Netherlands up to Br J Dermatol 2005; 152(3): Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 2004; 91(2): van Oost FJ, van der Hoeven JJ, Hoekstra OS, Voogd AC, Coebergh JW, van de Poll-Franse LV. Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography. Eur J Cancer 2004; 40(10): Di Bari M, van de Poll-Franse LV, Onder G, Kritchevsky SB, Newman A, Harris TB, Williamson JD, Marchionni N, Pahor M. Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004; 52(6): Martijn H, Voogd AC, van de Poll-Franse LV, Repelaer van Driel OJ, Rutten HJ, Coebergh JW. Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer 2003; 39(14): van de Poll-Franse LV, Valk GD, Renders CM, Heine RJ, van Eijk JT. Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors. Diabet Med 2002; 19(9): Pahor M, Franse LV, Deitcher SR, Cushman WC, Johnson KC, Shorr RI, Kottke-Marchant K, Tracy RP, Somes GW, Applegate WB. Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1. Circulation 2002; 105(4): Di Bari M, Pahor M, Barnard M, Gades N, Graney M, Franse LV, Penninx BW, Marchionni N, Applegate WB. Evaluation and correction for a 'training effect' in the cognitive assessment of older adults. Neuroepidemiology 2002; 21(2): Resnick HE, Shorr RI, Kuller L, Franse L, Harris TB. Prevalence and clinical implications of American Diabetes Association-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study. J Clin Epidemiol 2001; 54(9): Renders CM, Valk GD, Franse LV, Schellevis FG, van Eijk JT, van der Wal G. Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. Diabetes Care 2001; 24(8):

16 CV Lonneke van de Poll-Franse, March2015- long Franse LV, Di Bari M, Shorr RI, Resnick HE, van Eijk JT, Bauer DC, Newman AB, Pahor M. Type 2 diabetes in older well-functioning people: who is undiagnosed? Data from the Health, Aging, and Body Composition study. Diabetes Care 2001; 24(12): Di Bari M, Pahor M, Franse LV, Shorr RI, Wan JY, Ferrucci L, Somes GW, Applegate WB. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001; 153(1): Shorr RI, Franse LV, Resnick HE, Di Bari M, Johnson KC, Pahor M. Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, J Am Geriatr Soc 2000; 48(3): Franse LV, Valk GD, Dekker JH, Heine RJ, van Eijk JT. 'Numbness of the feet' is a poor indicator for polyneuropathy in Type 2 diabetic patients. Diabet Med 2000; 17(2): Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000; 35(5): Franse LV, Pahor M, Di Bari M, Shorr RI, Wan JY, Somes GW, Applegate WB. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18(8): National (refereed) journals 184. Siesling S, Visser O, Luth TK, Karim-Kos HE, van de Poll-Franse LV, Aben KK, Damhuis RA. [Adult cancer patients are surviving longer in the Netherlands: 5-year survival rate increased by 12% between the periods and ]. Ned Tijdschr Geneeskd. 2011;155:A3169. Dutch Veerbeek L, van de Poll-Franse LV, Bekkenk MW, Bergman W, Hoekstra HJ, Jansen-Landheer ML, Kruit WH, Mooi WJ, de Vries E, van der Rhee HJ. [Improved compliance with the 'Melanoma' treatment guideline]. Ned Tijdschr Geneeskd. 2010;154:A858. Dutch Van der Sangen MJ, Voogd AC, van de Poll-Franse LV, Tjan-Heijnen VC. [Breast cancer in young women: epidemiology and treatment dilemmas]. Ned Tijdschr Geneeskd 2008; 152(46): Van den Hurk CJ, van de Poll-Franse LV, Nolthenius-Puylaert MC, Roukema JA, van der Sangen MJ, Nieuwenhuijzen GA, van den Eijnden-van Raaij AJ, Coebergh JW. [Compliance with the breast cancer guidelines in the region of the Comprehensive Cancer Centre South, 20031/'04]. Ned Tijdschr Geneeskd 2006; 150(17): Siesling S, van de Poll-Franse LV, Jobsen JJ, Repelaer van Driel OJ, Voogd AC. [Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period ]. Ned Tijdschr Geneeskd 2005; 149(35): Janssen-Heijnen ML, Louwman WJ, van de Poll-Franse LV, Voogd AC, Houterman S, Coebergh JW. [Trends in the incidence and prevalence of cancer and in the survival of patients in southeastern Netherlands, ]. Ned Tijdschr Geneeskd 2003; 147(23): Books or contributions to books 1. Leerboek Oncologie. Hoofdstuk Kwaliteit van leven, uitgave in Signaleringscommissie kanker. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Amsterdam: KWF Kankerbestrijding, Janssen-Heijnen ML, Louwman WJ, van de Poll-Franse LV, Coebergh JW, Houterman S, Lemmens VE, Mols F, van der Sanden GAC, Vulto JC, Masseling HGMB, van der Heijden LH. Van meten naar weten, 50 jaar kankerregistratie. 1 ed. Valkenswaard: Drukkerij Valkenstadt B.V., Signaleringscommissie kanker. Kanker in Nederland. Trends, prognoses en implicaties voor zorgvraag. Amsterdam: KWF Kankerbestrijding, Franse LV. Type 2 diabetes: heterogeneity and clinical presentation [thesis]. ISBN Ponsen & Looyen, Wageningen, 2001.